Natural Killer Cell Lymphoma Market

Natural Killer Cell Lymphoma Market: Introduction

• The global natural killer cell lymphoma market has witnessed strong growth in the past few years due to wide applicability of these cells. Natural killer cells have the ability to kill virally infected cells, and detect and control early signs of cancer. Hence, these cells play a vital role in the human body. Some specialized natural killer cells are also found in the placenta and play an important role during pregnancy. Several pathological experiments utilize killer cells as important agents to counter microbial pathogens.
• Lymphoma is a common blood cancer, which develops when lymphocytes multiply in an uncontrolled manner. The two types of lymphomas are Hodgkin’s and non-Hodgkin’s lymphoma. Non-Hodgkin’s lymphoma is more common. Natural killer cell lymphoma is a type of non-Hodgkin’s lymphoma. The three types of natural killer cell lymphomas are extranodal, nasal type, and aggressive. Extranodal lymphomas occur in organs other than lymph nodes, and hence are called extranodal lymphomas. Nasal type of natural killer cell lymphoma usually affects nasal areas and paranasal sinuses. Aggressive form of the lymphoma is a fast growing cancer, because of which prognosis is difficult to study. Natural killer cell lymphomas are also shown to be associated with Epstein Barr Virus (EBV). Recommended treatments for natural killer cell lymphoma are chemotherapy, radiation therapy, targeted drug therapy, chimeric antigen receptor (CAR)-T cell therapy, bone marrow transplant, and immunotherapy.

Key Drivers, Restraints, and Opportunities of Global Natural Killer Cell Lymphoma Market

• Increase in awareness about the symptoms of natural killer cell lymphoma for early diagnosis of disease and easy availability of treatments are the major factors boosting the growth of the global natural killer cell lymphoma market. Moreover, increase in incidence of cancer is projected to boost the growth of the global market.
• Prolonged treatment and high cost of treatment of natural killer cell lymphoma deter patients to opt for the treatment. These factors are likely to restrain the global market.
• Availability of right information and support at the right time for patients presents significant opportunities in the global natural killer cell lymphoma treatment market. Moreover, R&D activities toward development of immunotherapy in the developing economies propels the global market.

North America to Capture Major Share of Global Natural Killer Cell lymphoma Market

• According to American Cancer Society statistics, non-Hodgkin lymphoma (NHL) is one of the most common cancers in the U.S., and accounts for about 4% of all cancers. According to estimations, about 81,560 people (45,630 males and 35,930 females) will be diagnosed with NHL in 2021. This includes both adults and children. North America is projected to account for major share of the global natural killer cell lymphoma market during the forecast period.
• Asia Pacific is anticipated to be a highly lucrative market for natural killer cell lymphoma treatment during the forecast period. Economic growth, improved health care facilities, rise in consumer awareness, and large geriatric population are the factors driving the market in the region.

Key Players Operating in Global Natural Killer Cell Lymphoma Market

The global natural killer cell lymphoma market is highly fragmented, with the presence of large number of key players. These players hold a major share in their respective regions. Major players operating in the global natural killer cell lymphoma market are:

• AbbVie, Inc.
• American Type Culture Collection (ATCC), Inc.
• AstraZeneca
• Bayer AG
• Bristol Myers Squibb Company
• Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
• HemaCare
• Janssen Pharmaceuticals, Inc.
• Kite Pharma, Inc. / Gilead Sciences, Inc.
• Kyowa Kirin Co., Ltd.
• Merck & Co., Inc.
• Merck Millipore Corporation
• Moffitt Cancer Center
• Novartis AG
• NYU Langone Hospitals
• ReeLabs Pvt. Ltd.
• Sanofi
• Sanofi-Aventis LLC
• Spectrum Pharmaceuticals, Inc.
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceutical Industries Ltd.
• The Denvax Clinics
• Optimum Therapeutics
• Other prominent players

Global Natural Killer Cell Lymphoma Market: Research Scope

Global Natural Killer Cell Lymphoma Market, by Diagnostics

• Blood & Urine Tests
• Imaging Tests
• Lymph Node Test
• Bone Marrow Test
• Lumbar Puncture (spinal tap)
• Others

Global Natural Killer Cell Lymphoma Market, by Treatment

• Chemotherapy
• Radiation Therapy
• Targeted Drug Therapy
• Chimeric Antigen Receptor (CAR)-T Cell Therapy
• Bone Marrow Transplant
• Immunotherapy

Global Natural Killer Cell Lymphoma Market, by End user

• Diagnostic Centers
• Hospitals
• Others

Global Natural Killer Cell Lymphoma Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa